Active Treatment Improves Overall Survival in Extremely Older Non-Small Cell Lung Cancer Patients: A Multicenter Retrospective Cohort Study
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose As the aging of society progresses, the proportion of extremely older lung cancer patients has also increased; However, studies of these patients with non–small cell lung cancer are limited. Therefore, we investigated the initial treatment modalities and survival outcomes for patients aged 80 years or over. Materials and Methods We included a multicenter retrospective cohort from the Korean Association for Lung Cancer Registry, which surveys 10% of the newly diagnosed lung cancer patients across 52 hospitals in Korea. We analyzed and compared the 2014-2016 data of the non–small cell lung cancer patients aged ≥ 80 years and those aged < 80 years. Results Of the 6,576 patients reviewed, 780 patients were aged ≥ 80 years, and 5,796 patients were aged < 80 years. In the patients aged ≥ 80 years, surgery and radiation therapy resulted in longer patient survival among those with a resectable tumor (stage I-II) than the best supportive care (median survival, not reached [surgery] vs. 32.2 months [radiation therapy] vs. 11.43 months [best supportive care]). The duration of survival in patients with advanced-stage (IV) lung cancers was higher after chemotherapy than after the best supportive care (median survival, 8.63 months vs. 2.5 months). Patients with stage IV adenocarcinoma who received targeted therapy had better survival than those who did not (median survival, 9.0 months vs. 4.3 months). Conclusion Even in extremely older patients, active treatments, such as surgery, radiation therapy, and chemotherapy, can result in better survival outcomes than the best supportive care.
Abstract
Purpose As the aging of society progresses, the proportion of extremely older lung cancer patients has also increased; However, studies of these patients with non–small cell lung cancer are limited. Therefore, we investigated the initial treatment modalities and survival outcomes for patients aged 80 years or over. Materials and Methods We included a multicenter retrospective cohort from the Korean Association for Lung Cancer Registry, which surveys 10% of the newly diagnosed lung cancer patients across 52 hospitals in Korea. We analyzed and compared the 2014-2016 data of the non–small cell lung cancer patients aged ≥ 80 years and those aged < 80 years. Results Of the 6,576 patients reviewed, 780 patients were aged ≥ 80 years, and 5,796 patients were aged < 80 years. In the patients aged ≥ 80 years, surgery and radiation therapy resulted in longer patient survival among those with a resectable tumor (stage I-II) than the best supportive care (median survival, not reached [surgery] vs. 32.2 months [radiation therapy] vs. 11.43 months [best supportive care]). The duration of survival in patients with advanced-stage (IV) lung cancers was higher after chemotherapy than after the best supportive care (median survival, 8.63 months vs. 2.5 months). Patients with stage IV adenocarcinoma who received targeted therapy had better survival than those who did not (median survival, 9.0 months vs. 4.3 months). Conclusion Even in extremely older patients, active treatments, such as surgery, radiation therapy, and chemotherapy, can result in better survival outcomes than the best supportive care.
참고문헌 (17)
- Bray F, "Global cancer statistics 2018 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 68, pp.394~424 (2018)
- Chen YM, "Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitors", Lung Cancer, 98, pp.99~105 (2016)
- "Number of cancer occurrences, incidence rate by 24 carcinomas/sex/age (5 years)" (2018)[URL]
- Brown JS, "Age and the treatment of lung cancer", Thorax, 51, pp.564~568 (1996)
- Altundag O, "Many patients 80 years and older with advanced nonsmall cell lung cancer(NSCLC)can tolerate chemotherapy", J Thorac Oncol, 2, pp.141~146 (2007)
- Presley CJ, "Caring for the older population with advanced lung cancer", Am Soc Clin Oncol Educ Book, 37, pp.587~596 (2017)
- Venuta F, "Lung cancer in elderly patients", J Thorac Dis, 8, pp.S908~ (2016)
- Quoix E, "Advanced non-small cell lung cancer in elderly patients", Breathe, 9, pp.26~34 (2012)
- Hurria A, "Designing therapeutic clinical trials for older and frail adults with cancer: U13 conference recommendations", J Clin Oncol, 32, pp.2587~2594 (2014)
- Davidoff AJ, "Chemotherapy and survival benefit in elderly patients with advanced non-smallcell lung cancer", J Clin Oncol, 28, pp.2191~2197 (2010)
- Booton R, "Lung cancer 7 : management of lung cancer in elderly patients", Thorax, 58, pp.711~720 (2003)
- Lutz W, "The coming acceleration of global population ageing", Nature, 451, pp.716~719 (2008)
- 최창민, "Report of the Korean Association of Lung Cancer Registry (KALC-R), 2014", Cancer Research and Treatment, 51(4), pp.1400~1410 (2019), 대한암학회
- Oxnard GR, "Non-small cell lung cancer in octogenarians : treatment practices and preferences", J Thorac Oncol, 2, pp.1029~1035 (2007)
- Lee K, "Real-world treatment patterns for patients 80 years and older with early lung cancer : a nationwide claims study", BMC Pulm Med, 18, pp.127~ (2018)
- Spencer KL, "Surgery or radiotherapy for stage I lung cancer? An intention-to-treat analysis", Eur Respir J, 53, pp.1801568~ (2019)
- 박지영, "Epidemiology of Lung Cancer in Korea: Recent Trends", Tuberculosis and Respiratory Diseases, 79(2), pp.58~69 (2016), 대한결핵및호흡기학회